Clinical Trial Update: Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating vinorelbine with trastuzumab emtansine in pre-treated HER2-positive metastatic breast cancer has been terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab emtansine (ado-trastuzumab emtansine)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: University of Miami | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-04-17